ArticleACS omega2025
Crystalline Covalent Organic Framework Paper for Sweating Disorder Disease Analysis.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abnormal sweating is closely associated with the occurrence and progression of various serious diseases, yet quantitatively and accurately assessing sweat pore function remains challenging. In this study, a crystalline covalent organic framework (COF) paper was developed for precise sweat pore analysis of sweating disorders. The delicately designed COF system achieved high-contrast sweat-responsive color change through the doping of sweat contents while showing no response to water, greatly enhancing resistance to environmental humidity interference. The flexible COF paper, grown in situ on PVDF paper substrates, adapts well to various skin surfaces, successfully recording the distribution and activity information on sweat pores through the "sweat pore mapping" technique of absorbing picoliter sweat within only 2 min of contact. Using the COF paper to obtain naked eye visible active sweat pore image can be used for accurate analysis of sweat pore function. Preliminary clinical studies using the COF paper have shown their ability in early disease warning and their potential in auxiliary diagnosis for sweating disorders. Furthermore, the COF paper demonstrated potential in monitoring the efficacy of topical treatments for skin diseases, providing a valuable tool for prognosis tracking. This study showcases the effective utilization of the COF paper for sweat pore analysis, underscoring the significant potential of COFs for advancing precision clinical research.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.